Dana dhuwit perusahaan: Tempus (TEM)

Tandha merek Tempus Labs (TEM)

The aggressive hiring of bioinformaticians and AI specialists contrasts with the focus of Tempus AI, Inc (TEM) on the protected US market, where data regulation minimizes geopolitical risks. The volume of cash reserves demonstrates current liquidity, while 0.61 reflects the latest value of the metric. Business stability relies on access to biomedical datasets, government grants, and the development of personalized medicine.

TEM - Dhuwit awis lan setara dhuwit awis perusahaan Tempus AI, Inc. ing rentang 15.06.2024 - 21.11.2026

Rincian analitis perusahaan Tempus AI, Inc

Ringkesan analisis perusahaan:tempus.com
Produk merek Tempus

Tempus AI, Inc (TEM) leads the precision medicine sector by leveraging the world's largest database of clinical-molecular data. This cash position chart allows for an assessment of the high-liquid resources required to shield the business from market risks. This metric measures the free cash balance, revealing capital management efficiency and the risk of excessive capital freezing. A stable liquidity level confirms the company's financial resilience amidst fierce competition with big-tech behemoths.

Pesaing Tempus AI, Inc (TEM)

Volume dana dhuwit perusahaan QGEN|IONS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Repligen RGEN|RNA: Dhuwit awis lan setara dhuwit awis perusahaan|CRSP: Dhuwit awis perusahaan|GeneDx Corp (WGS) - Dhuwit awis perusahaan|RARE: Volume dana dhuwit perusahaan|BEAM - Aset likuid perusahaan|SRPT (Sarepta Therapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Twist Bioscience Inc (TWST)|Volume dana dhuwit perusahaan TXG|Aset likuid perusahaan Intellia|Stoke - Dhuwit awis perusahaan|BLFS: Dhuwit awis lan setara dhuwit awis perusahaan|Wave Life Sciences Corp - Volume dana dhuwit perusahaan|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis perusahaan|Sionna Therapeutics Inc (SION) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Prime Medicine Corp|Dana dhuwit perusahaan tayshagtx.com|QURE - Posisi dhuwit perusahaan|Dhuwit awis perusahaan MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Posisi dhuwit perusahaan|Volume dana dhuwit perusahaan SLDB (Solid Biosciences Inc.)|Sisa dhuwit perusahaan OCGN|PacBio Corp - Volume dana dhuwit perusahaan|Benitec Biopharma Inc. (BNTC) - Dhuwit awis perusahaan|DSGN: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan RCKT|Dhuwit awis perusahaan FDMT|Dhuwit awis lan setara dhuwit awis perusahaan LXEO (Lexeo Therapeutics)|Volume dana dhuwit perusahaan KRRO|Editas Medicine, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Silence Therapeutics Inc. SLN|Volume dana dhuwit perusahaan ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis perusahaan|Posisi dhuwit perusahaan Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis perusahaan|MGX - Aset likuid perusahaan|DTIL (Precision BioSciences Inc.) - Volume dana dhuwit perusahaan|generationbio.com (GBIO) - Aset likuid perusahaan|Dana dhuwit perusahaan Boundless Bio Inc (BOLD)|Volume dana dhuwit perusahaan Exicure Inc. (XCUR)|Dana dhuwit perusahaan imunon.com IMNN|Volume dana dhuwit perusahaan Phio Pharmaceuticals PHIO|Mustang Bio Inc - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan transcodetherapeutics.com|BNGO: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan APDN|BLUE (bluebirdbio.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan ImmunoPrecise Antibodies IPA|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan